• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Predictive Biosciences

edit

Predictive Biosciences, Inc., a molecular diagnostics company, develops diagnostic products for informed cancer management. It specializes in proteomics, diagnostics, oncology, and tumor biomarkers. The company offers biomarkers and proteomics-based assay technologies. These assays detect urinary biomarkers associated with the physiological changes resulting from cancer development and progression. It also provides Triage Monitoring Assay, which allows physicians to delay and invasive diagnostic procedures; Interval Monitoring Assay that is for surveillance and detection of cancer between follow-ups; and Stratification Assay, which supports a physician’s decision to manage a patient.

Predictive Biosciences, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.

Recent Milestones

edit

• 
  Predictive Biosciences — Predictive Biosciences renews prostate cancer biomarker deal (11/16/10)
  Posted 11/16/10 at 11:27am via masshightech.com
• 
  Predictive Biosciences — Predictive Biosciences Inc. and Epigenomics AG, a German company focused on cancer treatment, have extended their licensing deal related to a biomarker for prostate cancer. (11/16/10)
  Posted 11/17/10 at 4:59am via masshightech.com
• 
  Predictive Biosciences — Predictive Biosciences Inc. has appointed Thomas Ross as chief commercial officer and Randal Vader as vice president of clinical and regulatory affairs (9/28/10)
  Posted 9/28/10 at 10:23am via masshightech.com
• 
  Predictive Biosciences — Announce new hires (9/28/10)
  Posted 9/29/10 at 3:02am via masshightech.com
• 
  Predictive Biosciences received $25M in Series C funding. (6/18/10)
  Posted 6/20/10 at 3:45am via onbiovc.com
• 
  Predictive Biosciences acquired OncoDiagnostic Laboratory. (1/7/10)
  Posted 1/8/10 at 1:23am via masshightech.com
• 
  Predictive Biosciences received $21.8M in Series B funding. (10/16/08)
  Posted 2/21/13 at 5:14am via bizjournals.com
• 
  Predictive Biosciences received $10M in Series A funding. (12/18/06)
  Posted 2/21/13 at 5:19am via pehub.com
• 
  Predictive Biosciences added Eugene Chiu as Co-Founder & VP Business Development and Commercial Operations. (7/1/06)
  Posted 6/7/13 at 5:41am
• 
  Predictive Biosciences added Peter Klemm as President & CEO.
  Posted 1/8/10 at 1:14am
• 
  Predictive Biosciences added Michael A. Greeley as Director.
  Posted 11/4/10 at 5:44am
• 
  Predictive Biosciences added PIERRE CASSIGNEUL as Chief Executive Officer .
  Posted 2/21/13 at 5:07am
• 
  Predictive Biosciences added Anthony P. Shuber as Co-Founder & CTO.
  Posted 1/8/10 at 1:14am

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/8/10

Sources

1. Predictive Biosciences buys OncoDiagnostic Lab (masshightech.com) [edit]
2. Predictive Biosciences Raises $10 Million (pehub.com) [edit]
3. Predictive Biosciences nails $21.75M VC round (bizjournals.com) [edit]
4. Predictive Biosciences, Inc.: Series C $25M (onbiovc.com) [edit]
Mass High Tech (masshightech.com) [edit]
Ross, Vader named Predictive Biosciences execs (masshightech.com) [edit]
Mass High Tech (masshightech.com) [edit]
Predictive Biosciences renews prostate cancer biomarker deal (masshightech.com) [edit]